
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11090596
[patent_doc_number] => 20160287564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/085451
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23894
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15085451
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/085451 | METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS | Mar 29, 2016 | Abandoned |
Array
(
[id] => 11016718
[patent_doc_number] => 20160213671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'PROPHYLAXIS AND TREATMENT OF A NEURODEGENERATIVE DISEASE NOT BASED ON A PROTEIN-FOLDING DISORDER'
[patent_app_type] => utility
[patent_app_number] => 15/082409
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3534
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/082409 | Prophylaxis and treatment of a neurodegenerative disease not based on a protein-folding disorder | Mar 27, 2016 | Issued |
Array
(
[id] => 11082177
[patent_doc_number] => 20160279142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND A CDK4/6 INHIBITOR COMPOUND FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/080019
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16768
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080019
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080019 | COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND A CDK4/6 INHIBITOR COMPOUND FOR THE TREATMENT OF CANCER | Mar 23, 2016 | Abandoned |
Array
(
[id] => 11804436
[patent_doc_number] => 09545398
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-01-17
[patent_title] => 'Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide'
[patent_app_type] => utility
[patent_app_number] => 15/078911
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16116
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15078911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/078911 | Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide | Mar 22, 2016 | Issued |
Array
(
[id] => 11082129
[patent_doc_number] => 20160279094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'DIETARY AND NATURAL PRODUCT MANAGEMENT OF NEGATIVE SIDE EFFECTS OF CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/078590
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11091
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15078590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/078590 | Dietary and natural product management of negative side effects of cancer treatment | Mar 22, 2016 | Issued |
Array
(
[id] => 11002345
[patent_doc_number] => 20160199294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'SUBLINGUAL NALOXONE SPRAY'
[patent_app_type] => utility
[patent_app_number] => 15/076080
[patent_app_country] => US
[patent_app_date] => 2016-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14435
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/076080 | SUBLINGUAL NALOXONE SPRAY | Mar 20, 2016 | Abandoned |
Array
(
[id] => 10987335
[patent_doc_number] => 20160184280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'METHODS OF PREVENTING THE DEVELOPMENT OF MUCOSITIS AND RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/063256
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8968
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/063256 | METHODS OF PREVENTING THE DEVELOPMENT OF MUCOSITIS AND RELATED DISORDERS | Mar 6, 2016 | Abandoned |
Array
(
[id] => 11002416
[patent_doc_number] => 20160199365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => '2-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative Diseases'
[patent_app_type] => utility
[patent_app_number] => 15/059395
[patent_app_country] => US
[patent_app_date] => 2016-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13713
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059395
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/059395 | 2-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative Diseases | Mar 2, 2016 | Abandoned |
Array
(
[id] => 12404910
[patent_doc_number] => 09968565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Method for protection and improvement of liver health with meso-zeaxanthin compositions
[patent_app_type] => utility
[patent_app_number] => 15/058823
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 10
[patent_no_of_words] => 7457
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15058823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/058823 | Method for protection and improvement of liver health with meso-zeaxanthin compositions | Mar 1, 2016 | Issued |
Array
(
[id] => 11348778
[patent_doc_number] => 20160367518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/057017
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16434
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15057017
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/057017 | METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS | Feb 28, 2016 | Abandoned |
Array
(
[id] => 11879569
[patent_doc_number] => 09750724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases'
[patent_app_type] => utility
[patent_app_number] => 15/050394
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16909
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050394
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050394 | Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases | Feb 21, 2016 | Issued |
Array
(
[id] => 11047489
[patent_doc_number] => 20160244447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/047717
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41627
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047717
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047717 | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | Feb 18, 2016 | Issued |
Array
(
[id] => 11047497
[patent_doc_number] => 20160244455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME'
[patent_app_type] => utility
[patent_app_number] => 15/048007
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 51596
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/048007 | Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme | Feb 18, 2016 | Issued |
Array
(
[id] => 11047489
[patent_doc_number] => 20160244447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/047717
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41627
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047717
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047717 | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | Feb 18, 2016 | Issued |
Array
(
[id] => 11047489
[patent_doc_number] => 20160244447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/047717
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41627
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047717
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047717 | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | Feb 18, 2016 | Issued |
Array
(
[id] => 12165302
[patent_doc_number] => 09884060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'KIF5B-RET fusion molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/045716
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 43232
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045716
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/045716 | KIF5B-RET fusion molecules and uses thereof | Feb 16, 2016 | Issued |
Array
(
[id] => 12098132
[patent_doc_number] => 09855215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Methotrexate composition'
[patent_app_type] => utility
[patent_app_number] => 15/019244
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4520
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019244
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019244 | Methotrexate composition | Feb 8, 2016 | Issued |
Array
(
[id] => 10797722
[patent_doc_number] => 20160143878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'ANTIBACTERIAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/017932
[patent_app_country] => US
[patent_app_date] => 2016-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16616
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/017932 | ANTIBACTERIAL AGENT | Feb 7, 2016 | Abandoned |
Array
(
[id] => 14143039
[patent_doc_number] => 10251871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Compositions and methods for treatment of edema
[patent_app_type] => utility
[patent_app_number] => 15/549156
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 23784
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549156
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549156 | Compositions and methods for treatment of edema | Feb 4, 2016 | Issued |
Array
(
[id] => 12151492
[patent_doc_number] => 20180022756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'COMPOUNDS AND METHODS FOR PREVENTING OR TREATING SENSORY HAIR CELL DEATH'
[patent_app_type] => utility
[patent_app_number] => 15/547438
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 48951
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547438 | Compounds and methods for preventing or treating sensory hair cell death | Feb 4, 2016 | Issued |